GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » E10

Cardiff Oncology (FRA:XE7C) E10 : €-33.03 (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cardiff Oncology's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.225. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-33.03 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cardiff Oncology was 6.60% per year. The lowest was 6.60% per year. And the median was 6.60% per year.

As of today (2024-12-13), Cardiff Oncology's current stock price is €3.34. Cardiff Oncology's E10 for the quarter that ended in Sep. 2024 was €-33.03. Cardiff Oncology's Shiller PE Ratio of today is .


Cardiff Oncology E10 Historical Data

The historical data trend for Cardiff Oncology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology E10 Chart

Cardiff Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -39.36 -43.86 -41.45 -35.68

Cardiff Oncology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.76 -35.68 -37.52 -37.20 -33.03

Competitive Comparison of Cardiff Oncology's E10

For the Biotechnology subindustry, Cardiff Oncology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiff Oncology's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiff Oncology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cardiff Oncology's Shiller PE Ratio falls into.



Cardiff Oncology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cardiff Oncology's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.225/133.0289*133.0289
=-0.225

Current CPI (Sep. 2024) = 133.0289.

Cardiff Oncology Quarterly Data

per share eps CPI Adj_EPS
201412 -14.598 99.070 -19.602
201503 -21.954 99.621 -29.316
201506 -26.302 100.684 -34.752
201509 -14.755 100.392 -19.552
201512 -17.185 99.792 -22.909
201603 -23.276 100.470 -30.819
201606 -21.787 101.688 -28.502
201609 -21.812 101.861 -28.486
201612 -23.207 101.863 -30.307
201703 -21.542 102.862 -27.860
201706 -16.661 103.349 -21.446
201709 -7.098 104.136 -9.067
201712 -3.650 104.011 -4.668
201803 -5.053 105.290 -6.384
201806 -4.511 106.317 -5.644
201809 -0.943 106.507 -1.178
201812 -0.958 105.998 -1.202
201903 -0.903 107.251 -1.120
201906 -0.673 108.070 -0.828
201909 -0.627 108.329 -0.770
201912 -0.459 108.420 -0.563
202003 -0.371 108.902 -0.453
202006 -0.453 108.767 -0.554
202009 -0.161 109.815 -0.195
202012 -0.148 109.897 -0.179
202103 -0.118 111.754 -0.140
202106 -0.141 114.631 -0.164
202109 -0.145 115.734 -0.167
202112 -0.204 117.630 -0.231
202203 -0.227 121.301 -0.249
202206 -0.227 125.017 -0.242
202209 -0.202 125.227 -0.215
202212 -0.189 125.222 -0.201
202303 -0.233 127.348 -0.243
202306 -0.231 128.729 -0.239
202309 -0.206 129.860 -0.211
202312 -0.193 129.419 -0.198
202403 -0.202 131.776 -0.204
202406 -0.242 132.554 -0.243
202409 -0.225 133.029 -0.225

Add all the adjusted EPS together and divide 10 will get our e10.


Cardiff Oncology  (FRA:XE7C) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cardiff Oncology E10 Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiff Oncology Business Description

Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

Cardiff Oncology Headlines

No Headlines